| PTA | Percutaneous Thermal Ablation |
| HCC | Hepatocellular Carcinoma |
| BCLC | Barcelona Clinic Liver Cancer |
| US | Ultrasonography |
| RFS | Recurrence-Free Survival |
| AFP | Alpha-Fetoprotein |
| OS | Overall Survival |
| MELD | Model for End-Stage Liver Disease |
| NAFLD | Non-Alcoholic Fatty Liver Disease |
| ECOG | Eastern Cooperative Oncology Group |
| AASLD | American Association for the Study of Liver Disease |
| EASL | European Association for the Study of the Liver |
| BMI | Body Mass Index |
| ALBI | Albumin–Bilirubin |
| MRI | Magnetic Resonance Imaging |
| ASA | American Society of Anesthesiologists |
| CT | Computed Tomography |
| SIR | Society of Interventional Radiology |
| LTP | Local tumor progression |
| SD | Standard Deviation |
| IQR | Interquartile Range |
| AIC | Akaike Information Criterion |
| TACE | Transarterial Chemoembolization |
| OR | Odds Ratio |
| CI | Confidence Interval |
| HR | Hazard Ratio |
| NASH | Non-Alcoholic Steatohepatitis |